Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health

Globalization and Health

Bryan A Liang¹  Tim K Mackey¹ 

[1] Department of Anesthesiology, University of California San Diego School of Medicine, 200 W. Arbor Drive, San Diego, CA 92103-8770, USA

关键词: Cybercrime;    Counterfeit medicines;    Social media;    Global health;    Direct-to-consumer advertising;    Online pharmacies;    Internet governance;   

Others  :  805364
DOI  :  10.1186/1744-8603-9-45

 received in 2013-03-13, accepted in 2013-08-14,  发布年份 2013

【 摘 要 】

Background

Digital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These cybercriminal actors exploit available eDTCA mediums over the Internet to market their suspect products globally. Despite these risks, a detailed assessment of the public health, patient safety, and cybersecurity threats and governance mechanisms to address them has not been conducted.

Discussion

Illicit online pharmacies represent a significant global public health and patient safety risk. Existing governance mechanisms are insufficient and include lack of adequate adoption in national regulation, ineffective voluntary governance mechanisms, and uneven global law enforcement efforts that have allowed proliferation of these cybercriminals on the web. In order to effectively address this multistakeholder threat, inclusive global governance strategies that engage the information technology, law enforcement and public health sectors should be established.

Summary

Effective global “eHealth Governance” focused on cybercrime is needed in order to effectively combat illicit online pharmacies. This includes building upon existing Internet governance structures and coordinating partnership between the UN Office of Drugs and Crime that leads the global fight against transnational organized crime and the Internet Governance Forum that is shaping the future of Internet governance. Through a UNODC-IGF governance mechanism, investigation, detection and coordination of activities against illicit online pharmacies and their misuse of eDTCA can commence.

【 授权许可】

   
2013 Mackey and Liang; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]The World in 2013: ICT Facts and Figures. http://www.itu.int/en/ITU-D/Statistics/Pages/facts/default.aspx webcite
• [2]For one-third of U.S. adults, the internet is a diagnostic tool. http://www.pewinternet.org/Reports/2013/Health-online/Part-One/Section-1.aspx webcite
• [3]Health citizens in emerging countries seek health information online even more than their peers in developed economies. http://healthpopuli.com/2011/01/06/health-citizens-in-emerging-countries-seek-health-information-online-even-more-than-their-peers-in-developed-economies/ webcite
• [4]Eysenbach G: What is e-health? J Med Internet Res 2001, 3:e20.
• [5]Eysenbach G: Medicine 2.0: social networking, collaboration, participation, apomediation, and openness. J Med Internet Res 2008, 10:e22.
• [6]Eysenbach G: Recent advances: Consumer health informatics. BMJ 2000, 320:1713-1716.
• [7]Piette JD, Lun KC, Moura LA, Fraser HSF, Mechael PN, Powell J, Khoja SR: Impacts of e-health on the outcomes of care in low- and middle-income countries: where do we go from here? Bull World Health Organ 2012, 90:365-372.
• [8]Lewis T, Synowiec C, Lagomarsino G, Schweitzer J: E-health in low- and middle-income countries: findings from the Center for Health Market Innovations. Bull World Health Organ 2012, 90:332-340.
• [9]Black AD, Car J, Pagliari C, Anandan C, Cresswell K, Bokun T, McKinstry B, Procter R, Majeed A, Sheikh A: The impact of eHealth on the quality and safety of health care: a systematic overview. PLoS Med 2011, 8:e1000387.
• [10]Blaya JA, Fraser HSF, Holt B: E-health technologies show promise in developing countries. Health Aff 2010, 29:244-251.
• [11]Fjeldsoe BS, Marshall AL, Miller YD: Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med 2009, 36:165-173.
• [12]Mair FS, May C, O'Donnell C, Finch T, Sullivan F, Murray E: Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bull World Health Organ 2012, 90:357-364.
• [13]Liang BA, Mackey TK: Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res 2011, 13:e64.
• [14]Liang BA, Mackey T: Direct-to-consumer advertising with interactive internet media: global regulation and public health issues. JAMA 2011, 305:824-825.
• [15]Safety and security on the Internet: Challenges and advances in Member States. http://www.who.int/goe/publications/goe_security_web.pdf webcite
• [16]Mackey T, Liang B: Globalization, evolution and emergence of direct-to-consumer advertising: are emerging markets the next pharmaceutical marketing frontier. J Commer Biotechnol 2012, 18:58-64.
• [17]Mackey TK, Liang BA: Global reach of direct-to-consumer advertising using social media for illicit online drug sales. J Med Internet Res 2013, 15:e105.
• [18]Mintzes B: Direct to consumer advertising of prescription drugs. BMJ 2008, 337:a985.
• [19]Liang BA, Mackey T: Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales. Am J Law Med 2009, 35:125-184.
• [20]Mackey TK, Liang BA: The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011, 100:4571-4579.
• [21]Orizio G, Rubinelli S, Schulz PJ, Domenighini S, Bressanelli M, Caimi L, Gelatti U: “Save 30% if you buy today”. Online pharmacies and the enhancement of peripheral thinking in consumers. Pharmacoepidemiol Drug Saf 2010, 19:970-976.
• [22]Mackey TK: Global Health Diplomacy and the Governance of Counterfeit Medicines: A Mapping Exercise of Institutional Approaches. J Health Diplomacy 2013, 1:1-20.
• [23]Lewis JA: Cyber Security: Turning National Solutions Into International Cooperation. Washington D.C.: Center For Strategic & International Studies; 2003.
• [24]Mintzes B, Morgan S, Wright JM: Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS One 2009, 4:e5699.
• [25]Liang BA, Mackey T: Reforming direct-to-consumer advertising. Nat Biotechnol 2011, 29:397-400.
• [26]Mackenzie FJ, Jordens CFC, Ankeny RA, McPhee J, Kerridge IH: Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia. Intern Med J 2007, 37:224-228.
• [27]Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P: Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005, 293:1995-2002.
• [28]Donohue JM, Cevasco M, Rosenthal MB: A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007, 357:673-681.
• [29]Law MR, Majumdar SR, Soumerai SB: Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. BMJ 2008, 337:a1055.
• [30]Liang BA, Mackey TK: Vaccine shortages and suspect online pharmacy sellers. Vaccine 2012, 30:105-108.
• [31]Forman RF, Woody GE, McLellan T, Lynch KG: The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatr 2006, 163:1233-1238.
• [32]Mackey TK, Liang BA: Oncology and the internet: regulatory failure and reform. J Oncol Pract 2012, 8:341-343.
• [33]Liang BA, Mackey TK: Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics. J Med Internet Res 2012, 14:e27.
• [34]Liang BA, Mackey TK: Sexual medicine: Online risks to health-the problem of counterfeit drugs. Nat Rev Urol 2012, 9:480-482.
• [35]BeSafeRx: Know Your Online Pharmacy - Survey Highlights. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/BuyingMedicinesOvertheInternet/BeSafeRxKnowYourOnlinePharmacy/ucm318497.htm webcite
• [36]Internet Drug Outlet Identification Program Updated Progress Report for State and Federal Regulators: April 2012 – Re-Issued May 14. 2012. http://www.nabp.net/news/assets/IDOIReportApril11.pdf webcite
• [37]NABP Issues Rogue Online Pharmacy Public Health Alert. http://www.nabp.net/news/nabp-issues-rogue-online-pharmacy-public-health-alert/ webcite
• [38]Counterfeit medicines. http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html webcite
• [39]Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M: How to achieve international action on falsified and substandard medicines. BMJ 2012, 345:e7381.
• [40]SpamIt, Glavmed Pharmacy Networks Exposed. http://krebsonsecurity.com/2011/02/spamit-glavmed-pharmacy-networks-exposed/ webcite
• [41]Gernburd P, Jadad AR: Will spam overwhelm our defenses? Evaluating offerings for drugs and natural health products. PLoS Med 2007, 4:e274.
• [42]The IFPMA Ten Principles on Counterfeit Medicines. http://www.ifpma.org/fileadmin/content/News/2010/IFPMA_Ten_Principles_on_Counterfeit_Medicines_12May2010.pdf webcite
• [43]Counterfeit Drugs. http://www.phrma.org/issues/counterfeit-drugs webcite
• [44]Mackey TK, Liang BA: Separating online piracy from counterfeit medicines: The need for policy reform and a call to action. Health Pol Technol 2012, 1:120-122.
• [45]Mackey TK, Liang BA, Strathdee SA: Digital social media, youth and non-medical use of prescription drugs: the need for reform. J Med Internet Res
• [46]Drug Dealers on the Internet: Is the DEA enforcing the Ryan Haight Act?. http://www.legitscript.com/download/LegitScript-DEA-Rogue-Internet-Pharmacy-Analysis.pdf webcite
• [47]Ethical criteria for medicinal drug promotion. http://apps.who.int/medicinedocs/documents/whozip08e/whozip08e.pdf webcite
• [48]Understanding and Responding to Pharmaceutical Promotion: A Practical Guide. http://www.haiweb.org/10112010/DPM_ENG_Final_SEP10.pdf webcite
• [49]Lexchin J: Models for financing the regulation of pharmaceutical promotion. Global Health 2012, 8:24. BioMed Central Full Text
• [50]Carlisle G, Whitehouse D, Duquenoy P (Eds): eHealth: Legal, Ethical and Governance Challenges. Heidelberg: springer.com; 2012.
• [51]INTERPOL and pharmaceutical industry launch global initiative to combat fake medicines. http://www.interpol.int/News-and-media/News-media-releases/2013/PR031 webcite
• [52]International operation targets online sale of illicit medicines. http://www.interpol.int/News-and-media/News-media-releases/2013/PR077 webcite
• [53]Operations. http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Operations/Operation-Pangea webcite
• [54]Experts discuss the role of organized crime in the production and trade of fraudulent medicines. http://www.unodc.org/unodc/en/frontpage/2013/February/conference-focuses-on-the-role-of-organized-crime-in-the-trafficking-of-fraudulent-medicines.html?ref=fs4 webcite
• [55]International Narcotics Control Board warns of illegal online pharmacies selling drugs to youth. http://www.unodc.org/unodc/en/frontpage/2012/February/narcotics-control-board-warns-of-illegal-online-pharmacies-selling-drugs-to-youth.html webcite
• [56]Who We Are. http://www.safemedsonline.org/who-we-are/ webcite
• [57]About Us. http://safeonlinerx.com/about-us/ webcite
• [58]Baidu, govt agency combat fake online medical info. http://www.zdnet.com/cn/baidu-govt-agency-combat-fake-online-medical-info-7000011759/ webcite
• [59]Report of the Working Group on Internet Governance. http://www.wgig.org/docs/WGIGREPORT.pdf webcite
• [60]Basic Information: About WSIS. http://www.itu.int/wsis/basic/multistakeholder.html webcite
• [61]About the Internet Governance Forum. http://www.intgovforum.org/cms/aboutigf webcite
• [62]CETS 211 - Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health. http://conventions.coe.int/Treaty/EN/Treaties/Html/211.htm webcite
• [63]Participation. http://www.itu.int/wsis/participation/index.html webcite
• [64]The Multistakeholder Advisory Grouphttp://www.intgovforum.org/cms/magabout webcite
• [65]WSIS: Plan of Action. http://www.itu.int/wsis/docs/geneva/official/poa.html webcite
• [66]AD Feeder Workshop 101: Are we meeting the challenges of bringing content and access to the world?. http://www.intgovforum.org/cms/component/content/article/71-transcripts-/806-ad1-feeder-session-101-are-we-meeting-the-challenges-of-bringing-content-and-access-to-the-world webcite
• [67]International Trade and Internet Governance. http://www.intgovforum.org/cms/component/content/article/102-transcripts2010/648-80 webcite
• [68]SOP workshop 212: Privacy and Security in an Open/Realtime/Linked Data World. http://www.intgovforum.org/cms/component/content/article/108-transcripts/843-28-september-2011-sop-workshop-212-privacy-and-security-in-an-openrealtimelinked-data-world webcite
• [69]Criminals rake in $250 billion per year in counterfeit goods that pose health and security risks. http://www.unodc.org/unodc/en/frontpage/2012/July/criminals-rake-in-250-billion-per-year-in-counterfeit-goods-that-pose-health-security-risks-to-unsuspecting-public.html webcite
• [70]Resolution 20/6: Countering fraudulent medicines, in particular their trafficking. http://www.unodc.org/documents/commissions/CCPCJ/CCPCJ-ECOSOC/CCPCJ-ECOSOC-00/CCPCJ-ECOSOC-11/Resolution_20-6.pdf webcite
• [71]Commission on Crime Prevention and Criminal Justice: Report on the twentieth session (3 December 2010 and 11-15 April 2011). http://www.un.org/Docs/journal/asp/ws.asp?m=E/2011/30 webcite